Mendelian Genomics Research Consortium
The Mendelian Genomics Research Consortium is aimed at significantly increasing the proportion of Mendelian disorders with an identified genetic cause through enhanced data sharing, collaboration and an increased focus on the application of new technologies, sequencing strategies and analytical approaches.
The National Human Genome Research Institute intends to fund a Mendelian Genomics Research Consortium in 2020. The program will comprise of Mendelian Genomics Research Centers (MGRC) and a Mendelian Genomics Data Coordinating Center (DCC). The MGRCs will sequence samples from patients with Mendelian conditions and develop and apply novel approaches to discover causal variants. The centers will also aim to solve “unsolved” cases for which a candidate gene was not identified by solely using whole exome sequencing. The DCC will manage data release and disseminate findings; coordinate program logistics and administrative duties; and oversee an Opportunity Fund for follow-up functional studies of discoveries made by the Mendelian centers.
Applications for the program are due on April 15th, 2020 (see below). Applicants are strongly encouraged to submit letters of intent.
February 12, 2020, 12:00 - 1:30 p.m., Eastern, NHGRI hosted a pre-application webinar for the Mendelian Genomics Research Consortium funding opportunities. NHGRI staff members provided an overview of the two FOAs, the goals and objectives of the program, and the application review process. Attendees /p>
Participation in this webinar was optional and was not required to submit an application in response to RFA-HG-20-007 or RFA-HG-20-2008.
Answers to Frequently Asked Questions will be made available.
Last updated: March 17, 2020